Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study

by Arpino, Grazia, De Placido, Sabino, De Angelis, Carmine
Published in Anticancer Drugs (2015)

ESR1 mutations as a mechanism for acquired endocrine resistance in breast cancer

by Jeselsohn, Rinath, Buchwalter, Gilles, De Angelis, Carmine, Brown, Myles, Schiff, Rachel
Published in Nat Rev Clin Oncol (2015)

The Changing Role of ER in Endocrine Resistance

by Nardone, Agostina, De Angelis, Carmine, Trivedi, Meghana V., Osborne, C. Kent, Schiff, Rachel
Published in Breast (2015)

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

by Ito, Koichi, Park, Sun Hee, Katsyv, Igor, Zhang, Weijia, De Angelis, Carmine, Schiff, Rachel, Irie, Hanna Y.
Published in NPJ Breast Cancer (2017)

Towards personalized treatment for early stage HER2-positive breast cancer

by Goutsouliak, Kristina, Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, De Angelis, Carmine, Osborne, C. Kent, Rimawi, Mothaffar F., Schiff, Rachel
Published in Nat Rev Clin Oncol (2019)

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy

by Perri, Francesco, Ionna, Franco, Longo, Francesco, Della Vittoria Scarpati, Giuseppina, De Angelis, Carmine, Ottaiano, Alessandro, Botti, Gerardo, Caponigro, Francesco
Published in Transl Oncol (2019)

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

by Veeraraghavan, Jamunarani, De Angelis, Carmine, Reis-Filho, Jorge S., Prat, Aleix, Rimawi, Mothaffar F., Pascual, Tomás, Osborne, C. Kent, Schiff, Rachel
Published in Breast (2017)

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research A...

by Moretti, Anna, Ghidini, Michele, De Angelis, Carmine, Lambertini, Matteo, Cremolini, Chiara, Imbimbo, Martina, Berardi, Rossana, Di Maio, Massimo, Cascinu, Stefano, La Verde, Nicla
Published in PLoS One (2016)

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

by Guarducci, Cristina, Bonechi, Martina, Benelli, Matteo, Biagioni, Chiara, Boccalini, Giulia, Romagnoli, Dario, Verardo, Roberto, Schiff, Rachel, Osborne, C. Kent, De Angelis, Carmine, Di Leo, Angelo, Malorni, Luca, Migliaccio, Ilenia
Published in NPJ Breast Cancer (2018)

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer

by Abdulkareem, Noor Mazin, Bhat, Raksha, Qin, Lanfang, Vasaikar, Suhas, Gopinathan, Ambily, Mitchell, Tamika, Shea, Martin J., Nanda, Sarmistha, Thangavel, Hariprasad, Zhang, Bing, De Angelis, Carmine, Schiff, Rachel, Trivedi, Meghana V.
Published in FASEB J (2021)

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie

by De Angelis, Carmine, Nardelli, Carmela, Concolino, Paola, Pagliuca, Martina, Setaro, Mario, De Paolis, Elisa, De Placido, Pietro, Forestieri, Valeria, Scaglione, Giovanni Luca, Ranieri, Annalisa, Lombardo, Barbara, Pastore, Lucio, De Placido, Sabino, Capoluongo, Ettore
Published in Front Oncol (2021)

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

by De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Published in Oncotarget (2017)

Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era

by Arpino, Grazia, De Angelis, Carmine, De Placido, Pietro, Pietroluongo, Erica, Formisano, Luigi, Bianco, Roberto, Fiore, Giovanni, Montella, Emma, Forestieri, Valeria, Lauria, Rossella, Cardalesi, Cinzia, Vozzella, Emilia Anna, Iervolino, Anna, Giuliano, Mario, De Placido, Sabino
Published in ESMO Open (2020)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy

by Arpino, Grazia, De Angelis, Carmine, Buono, Giuseppe, Colao, Annamaria, Giuliano, Mario, Malgieri, Simona, Cicala, Stefania, De Laurentiis, Michelino, Accurso, Antonello, Crispo, Anna, Limite, Gennaro, Lauria, Rossella, Veneziani, Bianca Maria, Forestieri, Valeria, Bruzzese, Dario, De Placido, Sabino
Published in Breast Cancer Res Treat (2015)

Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity

by Stossi, Fabio, Dandekar, Radhika D, Mancini, Maureen G, Gu, Guowei, Fuqua, Suzanne A W, Nardone, Agostina, De Angelis, Carmine, Fu, Xiaoyong, Schiff, Rachel, Bedford, Mark T, Xu, Wei, Johansson, Hans E, Stephan, Clifford C, Mancini, Michael A
Published in Nucleic Acids Res (2020)

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and an...

by Ramirez, Arturo B., Bhat, Raksha, Sahay, Debashish, De Angelis, Carmine, Thangavel, Hariprasad, Hedayatpour, Sina, Dobrolecki, Lacey E., Nardone, Agostina, Giuliano, Mario, Nagi, Chandandeep, Rimawi, Mothaffar, Osborne, C. Kent, Lewis, Michael T., Stilwell, Jackie L., Kaldjian, Eric P., Schiff, Rachel, Trivedi, Meghana V.
Published in BMC Cancer (2019)

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

by Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, Pensabene, Matilde, De Laurentiis, Michelino, Augustin, Livia Silvia Adriana, Amore, Alfonso, D'Aiuto, Massimiliano, Tortoriello, Raffaele, Accurso, Antonello, Cavalcanti, Ernesta, Botti, Gerardo, Montella, Maurizio, De Placido, Sabino, Arpino, Grazia
Published in Oncotarget (2017)

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

by Nardone, Agostina, Weir, Hazel, Delpuech, Oona, Brown, Henry, De Angelis, Carmine, Cataldo, Maria Letizia, Fu, Xiaoyong, Shea, Martin J., Mitchell, Tamika, Veeraraghavan, Jamunarani, Nagi, Chandandeep, Pilling, Mark, Rimawi, Mothaffar F., Trivedi, Meghana, Hilsenbeck, Susan G., Chamness, Gary C., Jeselsohn, Rinath, Osborne, C. Kent, Schiff, Rachel
Published in Br J Cancer (2018)

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

by Veeraraghavan, Jamunarani, Gutierrez, Carolina, Sethunath, Vidyalakshmi, Mehravaran, Sepideh, Giuliano, Mario, Shea, Martin J., Mitchell, Tamika, Wang, Tao, Nanda, Sarmistha, Pereira, Resel, Davis, Robert, Goutsouliak, Kristina, Qin, Lanfang, De Angelis, Carmine, Diala, Irmina, Lalani, Alshad S., Nagi, Chandandeep, Hilsenbeck, Susan G., Rimawi, Mothaffar F., Osborne, C. Kent, Schiff, Rachel
Published in NPJ Breast Cancer (2021)

Embryonic transcription factor SOX9 drives breast cancer endocrine resistance

by Jeselsohn, Rinath, Cornwell, MacIntosh, Pun, Matthew, Buchwalter, Gilles, Nguyen, Mai, Bango, Clyde, Huang, Ying, Kuang, Yanan, Paweletz, Cloud, Fu, Xiaoyong, Nardone, Agostina, De Angelis, Carmine, Detre, Simone, Dodson, Andrew, Mohammed, Hisham, Carroll, Jason S., Bowden, Michaela, Rao, Prakash, Long, Henry W., Li, Fugen, Dowsett, Mitchell, Schiff, Rachel, Brown, Myles
Published in Proc Natl Acad Sci U S A (2017)